PR

Media

HEM Pharma Received Approval from the U.S. Food and Drug Administration for Phase 2 Clinical Trial of a New Drug Candidate for Depression
2023.06.07

 

Read more >>>>  

에이치이엠파마, 美 FDA서 우울증 신약 후보물질 임상 2상 승인받아 

 
LIST